Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis

Por Yamanishi Tomonori, Abe Hideyuki, Arai Kyoko, Yanai Yoshiaki, Kamai Takao, Kurimoto Masashi, Yoshida Ken-Ichiro
Publicado em 2007-08-01

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis

Por Kamai, Takao, Yanai, Yoshiaki, Arai, Kyoko, Abe, Hideyuki, Yamanishi, Tomonori, Kurimoto, Masashi, Yoshida, Ken-Ichiro
Publicado em 2007

Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma

Por Nukui, Akinori, Yanai, Yoshiaki, Tsuzuki, Toyonori, Abe, Hideyuki, Arai, Kyoko, Yoshida, Ken-Ichiro, Kamai, Takao
Publicado no Oncotarget (2017)

Type 1 interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma

Por Tomiyama, Yasuyuki, Yoshioka, Naoko, Yanai, Yoshiaki, Kawase, Tomoya, Nishina, Sohji, Hara, Yuichi, Yoshida, Koji, Korenaga, Keiko, Korenaga, Masaaki, Hino, Keisuke
Publicado em 2011

Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma

Por Furuya, Nobutaka, Kamai, Takao, Shirataki, Hiromichi, Yanai, Yoshiaki, Fukuda, Takehiko, Mizuno, Tomoya, Nakamura, Fumihiko, Kambara, Tsunehito, Nakanishi, Kimihiro, Abe, Hideyuki, Yoshida, Ken-Ichiro
Publicado em 2011